Cannabis ETF

Fund Summary

The Global X Cannabis ETF (POTX) seeks to invest in companies across the cannabis industry. This includes companies involved in the legal production, growth and distribution of cannabis and industrial hemp, as well as those involved in providing financial services to the cannabis industry, pharmaceutical applications of cannabis, cannabidiol (i.e., CBD), or other related uses including but not limited to extracts, derivatives or synthetic versions.

Fund Objective

The Global X Cannabis ETF (POTX) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cannabis Index.


High Growth Potential

POTX enables investors to access a basket of high growth potential companies from across the cannabis industry.

Unconstrained Approach

POTX’s composition transcends classic sector, industry, and geographic classifications by tracking an emerging theme.

ETF Efficiency

In a single trade, POTX delivers targeted access to dozens of companies with significant exposure to the cannabis theme.

Fund Details As of 10/21/19

Key Facts

Ticker POTX
Inception Date 9/17/19
CUSIP 37954Y426
ISIN US37954Y4263
Bloomberg Index Ticker POTX
Primary Exchange Nasdaq

Stats & Fees

Net Assets $2,793,654
NAV $18.62
Shares Outstanding 150,000
Total Expense Ratio 0.50%


30-Day SEC Yield N/A
Distribution Frequency Semi-Annually

Fund Prices As of 10/21/19

NAV Price
Net Asset Value $18.62 Closing Price $18.72
Daily Change $0.13 0.73% Daily Change $0.16 0.83%

Performance History

Cumulative %

Data as of month end (9/30/19)

Fund NAV Closing Price Index
1 Month -- -- --
3 Months -- -- --
6 Months -- -- --
Since Inception -15.20% -16.20% --

Cumulative %

Data as of quarter end (9/30/19)

Fund NAV Closing Price Index
Since Inception -15.20% -16.20% --

Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized Return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted.

Fund Characteristics As of 10/21/19

Return on Equity -13.50%
Average Market Cap $943.00 M
2018 2019
Price-to-earnings -16.70 -21.22
Price-to-book value 2.68 3.07

Source: AltaVista Research, LLC

Top 10 Holdings

As of 10/21/19
Net Assets % Name Market Price ($) Shares Held Market Value ($)
9.35 GW PHARMACEUTICALS -ADR 121.48 2,151 261,303.48
8.95 CANOPY GROWTH CORP 20.28 12,333 250,114.73
8.26 CRONOS GROUP INC 8.47 27,231 230,709.54
8.09 APHRIA INC 4.79 47,214 225,952.59
7.16 AURORA CANNABIS INC 3.69 54,189 199,957.41
7.05 HEXO CORP 2.69 73,314 196,973.84
5.33 MEDIPHARM LABS CORP 3.26 45,648 148,774.54
5.08 ORGANIGRAM HOLDINGS INC 3.56 39,816 141,923.23
4.96 CORBUS PHARMACEU 5.22 26,520 138,434.40
4.82 CHARLOTTES WEB H 13.25 10,170 134,756.48
Holdings are subject to change. Cash, where shown, includes other assets and liabilities, such as payables and receivables.

Investing involves risk, including the possible loss of principal. The investable universe of companies in which POTX may invest may be limited. The Fund invests in securities of companies engaged in Healthcare and Pharmaceutical sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. POTX is non-diversified.

Cannabis companies are subject to various laws and regulations that may differ at the state/local, federal and international level. These laws and regulations may significantly affect a Cannabis Company’s ability to secure financing and traditional banking services, impact the market for cannabis business sales and services, and set limitations on cannabis use, production, transportation, export and storage. The Fund’s investments are concentrated in the cannabis industry, and the Fund may be susceptible to loss due to adverse occurrences affecting this industry.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Global X NAVs are calculated using prices as of 4:00 PM Eastern Time. The closing price is the Mid-Point between the Bid and Ask price as of the close of exchange. Closing price returns do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Since the Fund’s shares did not trade in the secondary market until several days after the Fund’s inception, for the period from inception to the first day of secondary market trading in Shares, the NAV of the Fund is used to calculate market returns.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Solactive AG, nor does Solactive AG make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Solactive AG.